9 completed, 1 not yet recruiting, 1 withdrawn. 11 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 9, Not yet recruiting 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Chlamydia Infections: new trials by email Literature Review of Chlamydia Infections trials Research Report on Chlamydia Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicentre Study Evaluating the Efficacy of a 7-day Course of Doxycycline for the Treatment of Asymptomatic Anal Lymphogranuloma Venereum. Doxycline - Lymphogranuloma Venereum, no Anorectal Symptoms | Phase 2 | Not yet recruiting | University Hospital, Bordeaux | 120 | 2026-09-01 | 2026-08-17 |
| Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma IR3535, Permethrin lower dose, Permethrin higher dose - Trachoma | Phase 2 | Completed | London School of Hygiene and Tropical Medicine | 64 | 2019-01-10 | 2020-04-08 |
| Online HIV Prevention for Young Male Couples 2GETHER, Existing Public Health Practice - Hiv, Chlamydia | Phase 2 | Completed | Northwestern University | 400 | 2018-04-05 | 2023-07-28 |
| YCFM (Youth Correctional Facilities Males) Azithromycin - Chlamydial Infection | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 100 | 2017-08-24 | 2019-10-28 |
| Randomized Trial of an HIV Prevention and Relationship Education Program for Young Male Couples 2GETHER, Positive Affect Enhancement - Hiv, Chlamydia | Phase 2 | Completed | Northwestern University | 256 | 2017-08-21 | 2023-02-08 |
| Nepal Elimination of Trachoma Study Azithromycin - Trachoma | Phase 2 / Phase 3 | Withdrawn | University of California, San Francisco | 2014-08-01 | 2015-05-21 | |
| Safer Sex Program for Young African-American Men Intervention - Gonorrhea, Chlamydia | Phase 2 | Completed | Richard Crosby | 620 | 2012-09-01 | 2019-02-21 |
| Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women Rifalazil 25 milligram, Azithromycin 1 gram - Chlamydia Trachomatis Infection | Phase 2 | Completed | ActivBiotics Pharma, LLC | 82 | 2012-07-01 | 2013-04-29 |
| Lay Health Advisors for Sexually Transmitted Disease Prevention HoMBReS: A lay health advisor approach to STD prevention - Syphilis, Gonorrhea | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 354 | 2004-10-01 | 2012-09-11 |
| The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services. Kit enhancement to referral, patient referral versus contract referral - Chlamydia Infection, Contact Tracing | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 494 | 2000-10-01 | 2012-09-27 |
| Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections Estrogen therapy - Atherosclerosis, Chlamydia Infections | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 80 | 1999-05-01 | 2008-03-04 |
Gonorrhea (4) · Acquired Immunodeficiency Syndrome (2) · HIV Infections (2) · Syphilis (2) · Trachoma (2) · Atherosclerosis (1) · Cytomegalovirus Infections (1) · Lymphogranuloma Venereum (1) · Pneumonia, Bacterial (1) · Sexually Transmitted Diseases (1) · Trichomonas Infections (1)
Bacterial Infections (11) · Bacterial Infections and Mycoses (11) · Chlamydiaceae Infections (11) · Gram-Negative Bacterial Infections (11) · Infections (11) · Communicable Diseases (9) · Genital Diseases (9) · Sexually Transmitted Diseases, Bacterial (9) · Urogenital Diseases (9) · Sexually Transmitted Diseases (8) · Virus Diseases (5) · Blood-Borne Infections (4) · Immune System Diseases (4) · Immunologic Deficiency Syndromes (4) · Lentivirus Infections (4)
Azithromycin (3) · Estrogen Replacement Therapy (1) · KRM 1648 (1) · Methods (1) · Permethrin (1) · ethyl-3-(N-n-butyl-N-acetyl)aminopropionate (1)
Centers for Disease Control and Prevention (2) · Northwestern University (2) · ActivBiotics Pharma, LLC (1) · London School of Hygiene and Tropical Medicine (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Richard Crosby (1) · University Hospital, Bordeaux (1) · University of California, San Francisco (1)
United States (8) · Ethiopia (1) · France (1) · Nepal (1) · United Kingdom (1)
Jim Carey, MPH (2) · Michael E Newcomb, Ph.D. (2) · Ricky Hill, Ph.D. (2) · Bruce D Gaynor, MD (1) · Chalom B Sayada, MD, PhD (1) · Guillermo Madico, PhD (1) · Leandro A Mena, MD (1) · Matthew Hogben, PhD (1) · Richard A Crosby, PhD (1) · Scott Rhodes, PhD (1)
PMID 37351709, PMID 24798277, PMID 32012111, PMID 35725624, PMID 35747196, PMID 37141032, PMID 39992776, PMID 40587318
K23EY019881 (1), R01MH092226 (1)